Aronne LJ, Sattar N, Horn DB, Bays HE, Wharton S, Lin WY, Ahmad NN, Zhang S, Liao R, Bunck MC, Jouravskaya I, Murphy MA, SURMOUNT-4 Investigators (2024) Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial
Oncogene 42 , 11011116 (2023)
PlexusDx Tirzepatide Access: No Insurance Required PlexusDx compounded tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan across all commitment tiers, with all medications sourced from licensed 503A compounding pharmacies and delivered to all 50 states
There is no official contraindication between creatine and tirzepatide, and no documented drug interaction exists in FDA labeling or major drug databases